Mabtas N 500 Mg Injection

Product Description

Product introduction

Mabtas N 500mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Mabtas N 500mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.

Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Advanced Cancer and Autoimmune Disease Therapy

Mabtas N 500 mg Injection employs the monoclonal antibody Rituximab to selectively target and eliminate abnormal B-cells. Its precision makes it highly suitable for diseases such as Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. The therapy supports patients who require effective immunosuppressive action, reflecting advances in targeted biological treatments available in India.


Administration and Handling Information

This medicine is given through intravenous infusion in a hospital setting by trained healthcare professionals. Proper storage in a refrigerator and avoiding freezing is crucial to preserve its efficacy. Mabtas N is available as a single-use vial containing 500 mg of Rituximab and should not be self-administered. Administration protocols strictly follow a physician's direction to maximize safety and treatment benefit.


Safety, Precautions, and Storage

Mabtas N 500 mg Injection is available only on prescription and should be used under medical supervision due to its potent immunosuppressive properties. Common precautions include careful monitoring during and after infusion, especially for infusion-related reactions. Store the vial between 2C and 8C, and do not freeze. Always check the shelf life and packaging to ensure product integrity before administration.